Model predicts recurrence of C. difficile infection

03/16/2014 |

A study in the journal Clinical Infectious Diseases found risk factors that may predict the likelihood of recurrence of Clostridium difficile infection. The model is based on data from pharmaceutical trials involving fidaxomicin and vancomycin. Researchers found that age, number of unformed bowel movements during the past 24 hours, creatinine levels and a history of prior infections can help define recurrence risk and also help clinicians determine the most effective treatments.

View Full Article in:

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA